ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
7,890.10
-0.91%
S&P ASX All Technology
3,489.20
-4.01%
Brent Oil
69.625
0.85%
US Dollar vs AUD
1.59
-0.17%
Bitcoin
81,562.00
3.94%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Cue Biopharma Inc (CUE) Share Price

Cue Biopharma Inc

Cue Biopharma Inc (CUE)

Cue Energy Resources Limited
1.03
-0.07
(-6.36%)
Closed 11 March 7:00AM
Delayed by 15 minutes
1.03
0.00
( 0.00% )
Pre Market: 7:05PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
1.03
Bid
0.95
Offer
1.64
Volume
-
0.00 Day's Range 0.00
0.45 52 Week Range 2.26
Market Cap
65.251M
Previous Close
1.03
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
288,394
Shares Outstanding
63,350,327
Dividend Yield
-
PE Ratio
-1.29
Earnings Per Share (EPS)
-0.8
Revenue
5.49M
Net Profit
-50.73M

About Cue Biopharma Inc

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant ... Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant form of the cytokine Interleukin-2 and a T cell antigen to target and activate T cells specific to HPV-related cancers. The other products under pipeline are CUE-102, CUE-103, CUE-400, and CUE-401. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.cuebiopharma.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Cue Biopharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CUE. The last closing price for Cue Biopharma was US$1.03. Over the last year, Cue Biopharma shares have traded in a share price range of US$ 0.45 to US$ 2.26.

Cue Biopharma currently has 63,350,327 shares in issue. The market capitalisation of Cue Biopharma is US$65.25 million. Cue Biopharma has a price to earnings ratio (PE ratio) of -1.29.

Ask ADVFN Intelligence (AI)

CUE Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
04 January 2025
CUE (-6.36%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
04 January 2025
CUE (-6.36%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
30 November 2024
CUE (-6.36%)

Form 3 - Initial statement of beneficial ownership of securities
Edgar (US Regulatory)
30 November 2024
CUE (-6.36%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
15 November 2024
CUE (-6.36%)

Form 8-K - Current report
Edgar (US Regulatory)
15 November 2024
CUE (-6.36%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.14-11.96581196581.171.210.98222727491.10834503CS
4-0.25-19.531251.281.540.98221857341.23249567CS
12-0.02-1.904761904761.051.750.94852883941.28527935CS
260.4783.92857142860.561.98910.455387731.26321265CS
52-0.94-47.71573604061.972.260.454368491.26755283CS
156-4.57-81.60714285715.66.290.453462752.51776441CS
260-16.02-93.958944281517.0535.50.453397577.30937626CS

CUE - Frequently Asked Questions (FAQ)

What is the current Cue Biopharma share price?
The current share price of Cue Biopharma is US$ 1.03
How many Cue Biopharma shares are in issue?
Cue Biopharma has 63,350,327 shares in issue
What is the market cap of Cue Biopharma?
The market capitalisation of Cue Biopharma is USD 65.25M
What is the 1 year trading range for Cue Biopharma share price?
Cue Biopharma has traded in the range of US$ 0.45 to US$ 2.26 during the past year
What is the PE ratio of Cue Biopharma?
The price to earnings ratio of Cue Biopharma is -1.29
What is the cash to sales ratio of Cue Biopharma?
The cash to sales ratio of Cue Biopharma is 11.88
What is the reporting currency for Cue Biopharma?
Cue Biopharma reports financial results in USD
What is the latest annual turnover for Cue Biopharma?
The latest annual turnover of Cue Biopharma is USD 5.49M
What is the latest annual profit for Cue Biopharma?
The latest annual profit of Cue Biopharma is USD -50.73M
What is the registered address of Cue Biopharma?
The registered address for Cue Biopharma is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Cue Biopharma website address?
The website address for Cue Biopharma is www.cuebiopharma.com
Which industry sector does Cue Biopharma operate in?
Cue Biopharma operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AWHAspira Womans Health Inc
US$ 0.3621
(82.88%)
29.2M
TSVT2seventy bio Inc
US$ 4.95
(76.79%)
362.73k
TNONTenon Medical Inc
US$ 2.05
(64.00%)
7.3M
ADTNADTRAN Holdings Inc
US$ 11.49
(35.34%)
41
SNOASonoma Pharmaceuticals Inc
US$ 3.75
(34.41%)
2.53M
PHATPhathom Pharmaceuticals Inc
US$ 2.00
(-54.55%)
120
MBXMBX Biosciences Inc
US$ 5.01
(-44.21%)
2
NEOGNeogen Corporation
US$ 6.03
(-39.58%)
8
JANXJanux Therapeutics Inc
US$ 20.05
(-33.65%)
21
XAGELongevity Health Holdings Inc
 0.2266
(-29.19%)
333.53k
AWHAspira Womans Health Inc
US$ 0.3621
(82.88%)
29.2M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 8.025
(8.74%)
13.58M
BTOGBit Origin Ltd
US$ 0.543
(14.29%)
11.51M
CUTRCutera Inc
US$ 0.142
(10.51%)
7.84M
TNONTenon Medical Inc
US$ 2.05
(64.00%)
7.3M

CUE Discussion

View Posts
boston127 boston127 2 months ago
Send URL for the funds loading info.

I also bought today and last week, but am RED because I bought at a higher price.
👍️0
Hawkeye_tt Hawkeye_tt 2 months ago
You can easily see when a Fund is loading for the day.
I backed up the truck in the 50 cent dip area. That was a gift.
GL all.....be patient.

Hawk
👍️0
boston127 boston127 2 months ago
Today's volume was heavier than usual,

trading 1,209,308 shares, versus an average of 459,032 shares per day during the last twelve months. The On Balance Volume indicator (OBV) shows that longer term selling pressure has given way to near term accumulation by traders.
👍️0
boston127 boston127 2 months ago
Momentum for CUE is strongly bullish.

The 14-period Slow Stochastic Oscillator is rising, as investors pay higher prices for shares. Good day today. Got back in recently. Will continue adding all the way to $3.
👍️0
boston127 boston127 2 months ago
Thanks. Interesting perspective.

As long as the company is doing well, I can wait and suffer through any dips.
👍️0
Hawkeye_tt Hawkeye_tt 2 months ago
This could be Over $5 right now...IMO. Algos/shorts walked this down for mths.
LT looks very good IMO.

Hawk
👍️0
boston127 boston127 2 months ago
Great day on Friday.

Wondering if profit taking will follow suit this week.
👍️0
Hawkeye_tt Hawkeye_tt 2 months ago
2025 should be a very good yr. New Partnerships and more.

Hawk
👍️0
glenn1919 glenn1919 2 months ago
cue.........................https://stockcharts.com/h-sc/ui?s=cue&p=W&b=5&g=0&id=p86431144783
👍️0
Hawkeye_tt Hawkeye_tt 5 months ago
TY for that quick dip/Algo dump op. Took advantage big time.
GL all...

Hawk
👍️0
boston127 boston127 5 months ago
Momentum for CUE is waning,

as measured by a 14-period Slow Stochastic Oscillator. This means that investors are less aggressive in their recent purchases and may even be taking profits in positions bought at lower prices.
👍️0
boston127 boston127 5 months ago
The On Balance Volume indicator (OBV) is bullish.

The slope of the indicator is positive and suggests that buyers are presently more active than sellers.Today's volume was heavier than usual, trading 2,320,021 shares, versus an average of 389,835 shares per day during the last twelve months.
👍️0
boston127 boston127 5 months ago
Momentum for CUE is strongly bullish.

The 14-period Slow Stochastic oscillator is above 80, the level which many analysts call overbought. This means that investors have been actively purchasing shares and driving the price higher.
👍️0
boston127 boston127 5 months ago
I got in on Friday. Everything

about the company is good. Gotta love it. They did not give up much to get that $11M in financing. Will buy on dips. Bought a little more today.
👍️0
Monksdream Monksdream 5 months ago
CUE under $2
👍️0
Hawkeye_tt Hawkeye_tt 5 months ago
Look at that Wkly candle ! Vol fantastic.
LT outlook back on !

Hawk
👍️0
Triple nickle Triple nickle 5 months ago
CUE ready to win 1.02
👍️0
Hawkeye_tt Hawkeye_tt 5 months ago
Strong recovery on news....future looking good here. Buy, hold LT...
Hawk
👍️0
Monksdream Monksdream 8 months ago
CUE new 52 week low
👍️0
Hawkeye_tt Hawkeye_tt 2 years ago
CUE....this story grows quickly. Merck early investor.
Last few wks it has been breaking out.
$5 break next. More Partners want in, on top of Ono.

Hawk
👍️0
conix conix 3 years ago
CUE Insider Buy
Cue Biopharma Aaron G.L. Fletcher Director Buy 735,000 shares @ $4.76 $3,498,600.00 3/31/2022
👍️0

Your Recent History

NASDAQ
CUE
Cue Biopharma
BOV
SOLR11
Solarium FII Fundo DE In...
BIT
NSCIT2206547
IFC
BIT
JPA
Exchange Traded Fund Ubs...
BIT
F13901
Vontobel Financial Produ...
BIT
I09008
Intesa Sanpaolo
BIT
I06744
Intesa Sanpaolo
BIT
UI707A
Unicredit Bank
BIBX
POAETH
POA Network
BIT
Q00415
Leonteq Securities
NASDAQ
CFUEX
Ci Portfolio Series Grow...
NASDAQ
CDOIX
Ci Global Energy Corpora...
NASDAQ
CFNVX
Ci North American Smallm...
NASDAQ
CCJNX
Ci Canadian Investment C...
NASDAQ
CAEQX
Canoe Bond Advantage Por...
NASDAQ
CEYZX
Ci Investment Grade Bond...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads